Metraipolis › archive › dc_dc122bbb4442

A Precision-Engineered DC-Targeting mRNA-LNP Neoantigen Vaccine Elicits Stronger T Cell Responses and Exhibits Superior Tumor Control — Europe PMC PMID:41893776

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41893776
DOI
10.3390/vaccines14030239
License (as archived)
solo-consultazione
Archived
2026-11-05T02:53:21.332Z
SHA-256 of the archived text
dca282c9d5ed36094869cd6400f20a85e708aeaacfac75d8bdf83dd259c2da69
Stable URL of this page
https://metraipolis.com/documento/dc_dc122bbb4442

How to cite

A Precision-Engineered DC-Targeting mRNA-LNP Neoantigen Vaccine Elicits Stronger T Cell Responses and Exhibits Superior Tumor Control — Europe PMC PMID:41893776 — Europe PMC (en), https://europepmc.org/article/MED/41893776 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc122bbb4442 (Metraipolis archive dc_dc122bbb4442, sha256 dca282c9d5ed36094869cd6400f20a85e708aeaacfac75d8bdf83dd259c2da69)
BibTeX
@misc{dcdc122bbb4442,
  title = {A Precision-Engineered DC-Targeting mRNA-LNP Neoantigen Vaccine Elicits Stronger T Cell Responses and Exhibits Superior Tumor Control — Europe PMC PMID:41893776},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41893776},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc122bbb4442; sha256 dca282c9d5ed36094869cd6400f20a85e708aeaacfac75d8bdf83dd259c2da69},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41893776. Agents can read the archived copy with the MCP tool read_document.